Expanding Temperature-Controlled Supply Chain Solutions With Vein-To-Vein Offerings

Cell and gene therapies hold promise to revolutionize the treatment of serious or life-threatening diseases with previously unmet medical needs. However, the stability and short shelf-life of these complex therapeutics present obstacles to manufacturers aiming to bring treatments to patients in need. Leveraging a partner experienced in controlled temperature GMP-complaint storage and fulfillment, secondary packaging/labeling, and kit production for advanced therapeutics is critical to advance your project to market.

Cryoport Systems has extended its expertise in temperature-controlled supply chain solutions with vein-to-vein BioServices offerings. BioServices expands our supply chain solutions in order to better serve our expanding clientele and the greater cell and gene industry.

There are many facets to our BioServices capabilities, including storage, secondary packaging & labeling, drug distribution, regulatory & QP services, drug return & destruction, and kit production. To offer specificity and detail into the breadth of BioServices, we sat down with Cryoport Systems’ Director of Bioservices Commercial Support, Bruce McAfee, and asked him to answer a few questions about BioServices and how it can support your organization and your patients.